세계의 이비인후과 내비게이션 시스템 시장 규모는 2024년에 4억 1,500만 달러에 달했습니다. 이 시장은 4.2%의 CAGR로 확대하며, 2031년에는 5억 5,000만 달러에 달할 것으로 예측됩니다.
신경외과수술과 달리 이비인후과 수술에서는 내비게이션 시스템이 보편적으로 필요한 것은 아닙니다. 비용이 비싸고 부피가 크며 추가 교육이 필요하므로 채택이 제한되어 있습니다.
정확도와 가격을 향상시키는 새로운 기술이 개발되고 있습니다. 내비게이션 지원 시술을 지지하는 연구 발표의 증가는 채택을 촉진할 것으로 예상됩니다.
세계의 이비인후과 내비게이션 시스템 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
The global ENT navigation system market was valued at $415 million in 2024 and is expected to grow at a CAGR of 4.2%, reaching $550 million by 2031.
This market is divided into three key segments:
Market insights & data coverage
Market trends & challenges
* Not yet the standard of care
* Unlike neurosurgery, ENT procedures do not universally require navigation systems.
* Higher costs, bulkiness, and additional training requirements limit adoption.
* New technology is being developed to improve accuracy and affordability.
* Increased publication of studies supporting navigation-assisted procedures is expected to drive adoption.
Market segmentation & growth trends
* Largest segment in 2024.
* Expected to grow at the slowest rate over the forecast period.
* Second-largest segment.
* Expected to grow at the second-fastest rate.
* Smallest segment in 2024.
* Expected to have the fastest growth rate over the forecast period.
* Capital equipment and services & maintenance will gain market share, while disposables & accessories will lose some share.
Market share insights
Top competitors in the global ENT navigation system market (2024):
1 Medtronic - Market leader in ENT navigation systems
* Offers StealthStation(TM) S8, a navigation system used for spinal, cranial, ENT, and orthopedic procedures.
* ENT-specific solutions include StealthStation(TM) ENT, StealthStation FlexENT(TM), FUSION(TM), and FUSION Compact(TM).
2 Brainlab - Second-largest market player
* Offers two image-guided surgery (IGS) systems:
* Kick(R) (commonly used for ENT procedures).
* Curve(TM) (available with two monitors).
3 Stryker - Third-largest market player
* Offers the Stryker NAV3i(R) platform, which supports spinal, cranial, ENT, and orthopedic procedures.
* Also provides Scopis' TGS(R) Target Guided Surgery Navigation System, specialized for ENT applications.
Market segmentation summary
Global research scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative coverage
Qualitative coverage
Data sources